Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Wittpenn

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Eye & Contact Lens|March 31, 2005
Crystallization of gatifloxacin after penetrating keratoplastyJohn R Wittpenn
Cornea|April 1, 2015
Topical NSAIDs effect on corneal sensitivityDaniel D Singer, John Kennedy, John R Wittpenn
American Journal of Ophthalmology Case Reports|March 5, 2021
<i>Nocardia</i> keratitis mimicking superior limbic keratoconjunctivitis and herpes simplex virusEileen L Chang, Rachel L Chu, John R Wittpenn, et al.
Current Eye Research|September 23, 2010
Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: tools for predicting responseMarguerite McDonald, Gerard D'Aversa, Henry D Perry, et al.
Cornea|April 26, 2002
Confocal microscopy in Meretoja syndromeAnna Rothstein, James D Auran, John R Wittpenn, et al.
Journal of Cataract and Refractive Surgery|August 26, 2006
Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curveEric D Donnenfeld, Henry D Perry, John R Wittpenn, et al.
American Journal of Ophthalmology|July 5, 2008
A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patientsJohn R Wittpenn, Steven Silverstein, Jeffrey Heier, et al.
Transactions of the American Ophthalmological Society|February 4, 2010
Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of lifeMarguerite McDonald, Gerard D'Aversa, Henry D Perry, et al.
Journal of Cataract and Refractive Surgery|July 9, 2010
Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantationEric D Donnenfeld, Renée Solomon, Calvin W Roberts, et al.
Cornea|March 17, 2011
The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapyMichael Y Su, Henry D Perry, Allon Barsam, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Eye & Contact Lens|March 31, 2005
Crystallization of gatifloxacin after penetrating keratoplastyJohn R Wittpenn
Cornea|April 1, 2015
Topical NSAIDs effect on corneal sensitivityDaniel D Singer, John Kennedy, John R Wittpenn
American Journal of Ophthalmology Case Reports|March 5, 2021
<i>Nocardia</i> keratitis mimicking superior limbic keratoconjunctivitis and herpes simplex virusEileen L Chang, Rachel L Chu, John R Wittpenn, et al.
Current Eye Research|September 23, 2010
Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: tools for predicting responseMarguerite McDonald, Gerard D'Aversa, Henry D Perry, et al.
Cornea|April 26, 2002
Confocal microscopy in Meretoja syndromeAnna Rothstein, James D Auran, John R Wittpenn, et al.
Journal of Cataract and Refractive Surgery|August 26, 2006
Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curveEric D Donnenfeld, Henry D Perry, John R Wittpenn, et al.
American Journal of Ophthalmology|July 5, 2008
A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patientsJohn R Wittpenn, Steven Silverstein, Jeffrey Heier, et al.
Transactions of the American Ophthalmological Society|February 4, 2010
Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of lifeMarguerite McDonald, Gerard D'Aversa, Henry D Perry, et al.
Journal of Cataract and Refractive Surgery|July 9, 2010
Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantationEric D Donnenfeld, Renée Solomon, Calvin W Roberts, et al.
Cornea|March 17, 2011
The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapyMichael Y Su, Henry D Perry, Allon Barsam, et al.
Pageof 2